in the patients' first colonoscopies: age, sex, a first-degree relative with colorectal cancer, tobacco use, and waist circumference. ... Similar results were found in the validation group. “This strategy could improve the efficiency and uptake of
The New England Journal of Medicine published two major papers on screening for colon and rectal cancer. ... According to the ACS, colorectal cancer ranks third as a cause of cancer mortality in men and in women.
Among the most talked-about research presented at the conference was a new study finding obesity to be the greatest risk factor for colorectal cancer in women. ... Assuming further studies confirm the association between obesity and colorectal cancer,
Multi-Society Task Force on Colorectal Cancer and the American College of Radiology, in May and the other by the U.S. ... Promote prevention. Be clear to patients that colorectal cancer screening is absolutely effective and important preventive strategy
QD: News Every Day--End-of-life planning reduces aggressive treatment in a patient's last month of life
Early discussions of end-of-life planning (EOL) in patients with incurable cancer led to less chemotherapy in the last two weeks of life, and less time spent in the ICU ... Researchers studied 1,231 patients with stage IV lung or colorectal cancer who
Albandar HJ, Markert R, Agrawal S. The relationship between aspirin use and mortality in colorectal cancer. ... Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S.
According to the ACS, colorectal cancer ranks third as a cause of cancer mortality in men and in women. ... My take from these reports, combined, is that periodic colonoscopy has the potential to halve the number of deaths from colon cancer in the
Higher quantity drinking (=three drinks per day vs. one drink per day) increased the all-site cancer mortality risk among men and women, as well as increased risk of colorectal cancer ... Prospective study of alcohol consumption quantity and frequency
The study found that primary care physicians lacked confidence in their knowledge of the follow-up care of breast and colorectal cancer patients, and oncologists not only shared this opinion of ... Virgo KS, Lerro CC, Klabunde CN, et al. Barriers in
Ado-trastuzumab emtansine (Kadcyla) to treat HER2-positive, metastatic breast cancer. The drug is intended for patients who were previously treated with trastuzumab and taxanes. ... The drug was approved to treat colorectal cancer in September 2012.